Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation

Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation

Show other versions (1)

Background: Clinical trials in cystic fibrosis (CF) have been hindered by the paucity of well characterised and clinically relevant outcome measures. Aim: To evaluate a range of conventional and novel biomarkers of CF lung disease in a multicentre setting as a contributing study in selecting outcome...

Full description

Bibliographic Details
Main Authors: Horsley, A, Davies, J, Gray, R, MacLeod, K, Donovan, J, Aziz, Z, Bell, N, Rainer, M, Mt-Isa, S, Voase, N, Dewar, M, Saunders, C, Gibson, J, Parra-Leiton, J, Larsen, MD, Jeswiet, S, Soussi, S, Bakar, Y, Meister, MG, Tyler, P, Doherty, A, Hansell, D, Ashby, D, Hyde, S, Gill, DR
Format: Journal article
Language:English
Published: 2013

Similar Items